Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Oct;9(4):499–511. doi: 10.1128/cmr.9.4.499

Epidemiology of nosocomial fungal infections.

S K Fridkin 1, W R Jarvis 1
PMCID: PMC172907  PMID: 8894349

Abstract

This paper briefly reviews the current knowledge of the epidemiology and modes of transmission of nosocomial fungal infections and some of the therapeutic options for treating these diseases. In the mid-1980s, many institutions reported that fungi were common pathogens in nosocomial infections. Most, if not all, hospitals care for patients at risk for nosocomial fungal infections. The proportion in all nosocomial infections reportedly caused by Candida spp. increased from 2% in 1980 to 5% in 1986 to 1989. Numerous studies have identified common risk factors for acquiring these infections, most of which are very common among hospitalized patients; some factors act primarily by inducing immunosuppression (e.g., corticosteroids, chemotherapy, malnutrition, malignancy, and neutropenia), while others primarily provide a route of infection (e.g., extensive burns, indwelling catheter), and some act in combination. Non-albicans Candida spp., including fluconazole-resistant C. krusei and Torulopsis (C.) glabrata, have become more common pathogens. Newer molecular typing techniques can assist in the determination of a common source of infection caused by several fungal pathogens. Continued epidemiologic and laboratory research is needed to better characterize these pathogens and allow for improved diagnostic and therapeutic strategies.

Full Text

The Full Text of this article is available as a PDF (361.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisner J., Schimpff S. C., Bennett J. E., Young V. M., Wiernik P. H. Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. JAMA. 1976 Jan 26;235(4):411–412. [PubMed] [Google Scholar]
  2. Anaissie E. J., Bodey G. P., Rinaldi M. G. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):323–330. doi: 10.1007/BF01963467. [DOI] [PubMed] [Google Scholar]
  3. Anaissie E., Bodey G. P. Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am. 1989 Dec;3(4):867–882. [PubMed] [Google Scholar]
  4. Arnow P. M., Andersen R. L., Mainous P. D., Smith E. J. Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis. 1978 Jul;118(1):49–53. doi: 10.1164/arrd.1978.118.1.49. [DOI] [PubMed] [Google Scholar]
  5. Arnow P. M., Sadigh M., Costas C., Weil D., Chudy R. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. J Infect Dis. 1991 Nov;164(5):998–1002. doi: 10.1093/infdis/164.5.998. [DOI] [PubMed] [Google Scholar]
  6. Banerjee S. N., Emori T. G., Culver D. H., Gaynes R. P., Jarvis W. R., Horan T., Edwards J. R., Tolson J., Henderson T., Martone W. J. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):86S–89S. doi: 10.1016/0002-9343(91)90349-3. [DOI] [PubMed] [Google Scholar]
  7. Barg N. L. An introduction to molecular hospital epidemiology. Infect Control Hosp Epidemiol. 1993 Jul;14(7):395–396. doi: 10.1086/646768. [DOI] [PubMed] [Google Scholar]
  8. Beck-Sagué C., Jarvis W. R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993 May;167(5):1247–1251. doi: 10.1093/infdis/167.5.1247. [DOI] [PubMed] [Google Scholar]
  9. Bennett S. N., McNeil M. M., Bland L. A., Arduino M. J., Villarino M. E., Perrotta D. M., Burwen D. R., Welbel S. F., Pegues D. A., Stroud L. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995 Jul 20;333(3):147–154. doi: 10.1056/NEJM199507203330303. [DOI] [PubMed] [Google Scholar]
  10. Bodey G. P. The emergence of fungi as major hospital pathogens. J Hosp Infect. 1988 Feb;11 (Suppl A):411–426. doi: 10.1016/0195-6701(88)90220-4. [DOI] [PubMed] [Google Scholar]
  11. Borg-von Zepelin M., Eiffert H., Kann M., Rüchel R. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Göttingen, Germany. Mycoses. 1993 Jul-Aug;36(7-8):247–253. doi: 10.1111/j.1439-0507.1993.tb00759.x. [DOI] [PubMed] [Google Scholar]
  12. Branchini M. L., Pfaller M. A., Rhine-Chalberg J., Frempong T., Isenberg H. D. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol. 1994 Feb;32(2):452–456. doi: 10.1128/jcm.32.2.452-456.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bross J., Talbot G. H., Maislin G., Hurwitz S., Strom B. L. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med. 1989 Dec;87(6):614–620. doi: 10.1016/s0002-9343(89)80392-4. [DOI] [PubMed] [Google Scholar]
  14. Brown N. M., Blundell E. L., Chown S. R., Warnock D. W., Hill J. A., Slade R. R. Acremonium infection in a neutropenic patient. J Infect. 1992 Jul;25(1):73–76. doi: 10.1016/0163-4453(92)93585-e. [DOI] [PubMed] [Google Scholar]
  15. Codish S. D., Sheridan I. D., Monaco A. P. Mycotic wound infections. A new challenge of the surgeon. Arch Surg. 1979 Jul;114(7):831–835. doi: 10.1001/archsurg.1979.01370310073013. [DOI] [PubMed] [Google Scholar]
  16. Colombo A. L., Barchiesi F., McGough D. A., Rinaldi M. G. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol. 1995 Mar;33(3):535–540. doi: 10.1128/jcm.33.3.535-540.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dankner W. M., Spector S. A., Fierer J., Davis C. E. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis. 1987 Jul-Aug;9(4):743–753. doi: 10.1093/clinids/9.4.743. [DOI] [PubMed] [Google Scholar]
  18. Danna P. L., Urban C., Bellin E., Rahal J. J. Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet. 1991 Mar 2;337(8740):511–514. doi: 10.1016/0140-6736(91)91296-7. [DOI] [PubMed] [Google Scholar]
  19. Dubé M. P., Heseltine P. N., Rinaldi M. G., Evans S., Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis. 1994 Jan;18(1):77–82. doi: 10.1093/clinids/18.1.77. [DOI] [PubMed] [Google Scholar]
  20. Edwards J. E., Jr Invasive candida infections--evolution of a fungal pathogen. N Engl J Med. 1991 Apr 11;324(15):1060–1062. doi: 10.1056/NEJM199104113241511. [DOI] [PubMed] [Google Scholar]
  21. Eickhoff T. C. Airborne nosocomial infection: a contemporary perspective. Infect Control Hosp Epidemiol. 1994 Oct;15(10):663–672. doi: 10.1086/646830. [DOI] [PubMed] [Google Scholar]
  22. Emori T. G., Gaynes R. P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993 Oct;6(4):428–442. doi: 10.1128/cmr.6.4.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fincher R. M., Fisher J. F., Lovell R. D., Newman C. L., Espinel-Ingroff A., Shadomy H. J. Infection due to the fungus Acremonium (cephalosporium). Medicine (Baltimore) 1991 Nov;70(6):398–409. doi: 10.1097/00005792-199111000-00005. [DOI] [PubMed] [Google Scholar]
  24. Finkelstein R., Reinhertz G., Hashman N., Merzbach D. Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 1993 Oct;14(10):587–590. doi: 10.1086/646643. [DOI] [PubMed] [Google Scholar]
  25. Fisher-Hoch S. P., Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis. 1995 Oct;21(4):897–904. doi: 10.1093/clinids/21.4.897. [DOI] [PubMed] [Google Scholar]
  26. Fisher D. J., Christy C., Spafford P., Maniscalco W. M., Hardy D. J., Graman P. S. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Pediatr Infect Dis J. 1993 Feb;12(2):149–155. [PubMed] [Google Scholar]
  27. Fraser V. J., Jones M., Dunkel J., Storfer S., Medoff G., Dunagan W. C. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992 Sep;15(3):414–421. doi: 10.1093/clind/15.3.414. [DOI] [PubMed] [Google Scholar]
  28. Fridkin S. K., Kremer F. B., Bland L. A., Padhye A., McNeil M. M., Jarvis W. R. Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir. Clin Infect Dis. 1996 Feb;22(2):222–227. doi: 10.1093/clinids/22.2.222. [DOI] [PubMed] [Google Scholar]
  29. Galgiani J. N., Reiser J., Brass C., Espinel-Ingroff A., Gordon M. A., Kerkering T. M. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother. 1987 Sep;31(9):1343–1347. doi: 10.1128/aac.31.9.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gerson S. L., Parker P., Jacobs M. R., Creger R., Lazarus H. M. Aspergillosis due to carpet contamination. Infect Control Hosp Epidemiol. 1994 Apr;15(4 Pt 1):221–223. [PubMed] [Google Scholar]
  31. Girardin H., Sarfati J., Traoré F., Dupouy Camet J., Derouin F., Latgé J. P. Molecular epidemiology of nosocomial invasive aspergillosis. J Clin Microbiol. 1994 Mar;32(3):684–690. doi: 10.1128/jcm.32.3.684-690.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Goodman J. L., Winston D. J., Greenfield R. A., Chandrasekar P. H., Fox B., Kaizer H., Shadduck R. K., Shea T. C., Stiff P., Friedman D. J. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992 Mar 26;326(13):845–851. doi: 10.1056/NEJM199203263261301. [DOI] [PubMed] [Google Scholar]
  33. Gupta T. P., Ehrinpreis M. N. Candida-associated diarrhea in hospitalized patients. Gastroenterology. 1990 Mar;98(3):780–785. doi: 10.1016/0016-5085(90)90303-i. [DOI] [PubMed] [Google Scholar]
  34. Hajjeh R. A., Blumberg H. M. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin Infect Dis. 1995 Apr;20(4):913–916. doi: 10.1093/clinids/20.4.913. [DOI] [PubMed] [Google Scholar]
  35. Harvey R. L., Myers J. P. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med. 1987 Dec;147(12):2117–2120. [PubMed] [Google Scholar]
  36. Horn R., Wong B., Kiehn T. E., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985 Sep-Oct;7(5):646–655. doi: 10.1093/clinids/7.5.646. [DOI] [PubMed] [Google Scholar]
  37. Iwata K. Drug resistance in human pathogenic fungi. Eur J Epidemiol. 1992 May;8(3):407–421. doi: 10.1007/BF00158576. [DOI] [PubMed] [Google Scholar]
  38. Iwen P. C., Davis J. C., Reed E. C., Winfield B. A., Hinrichs S. H. Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol. 1994 May;15(5):303–306. doi: 10.1086/646916. [DOI] [PubMed] [Google Scholar]
  39. Jeffrey W. R., Hernandez J. E., Zarraga A. L., Oley G. E., Kitchen L. W. Disseminated infection due to Acremonium species in a patient with Addison's disease. Clin Infect Dis. 1993 Jan;16(1):170–170. doi: 10.1093/clinids/16.1.170. [DOI] [PubMed] [Google Scholar]
  40. Kammer R. B., Utz J. P. Aspergillus species endocarditis. The new face of a not so rare disease. Am J Med. 1974 Apr;56(4):506–521. doi: 10.1016/0002-9343(74)90483-5. [DOI] [PubMed] [Google Scholar]
  41. Karabinis A., Hill C., Leclercq B., Tancrède C., Baume D., Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988 Mar;26(3):429–432. doi: 10.1128/jcm.26.3.429-432.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Komshian S. V., Uwaydah A. K., Sobel J. D., Crane L. R. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 1989 May-Jun;11(3):379–390. doi: 10.1093/clinids/11.3.379. [DOI] [PubMed] [Google Scholar]
  43. Kontou-Kastellanou C., Leonardopoulos J., Boniatsi L., Kastellanos S., Toutouzas P. A case of Candida parapsilosis endocarditis. Mycoses. 1990 Sep-Oct;33(9-10):427–429. doi: 10.1111/myc.1990.33.9-10.427. [DOI] [PubMed] [Google Scholar]
  44. Lecciones J. A., Lee J. W., Navarro E. E., Witebsky F. G., Marshall D., Steinberg S. M., Pizzo P. A., Walsh T. J. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis. 1992 Apr;14(4):875–883. doi: 10.1093/clinids/14.4.875. [DOI] [PubMed] [Google Scholar]
  45. Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992 Jul 2;327(1):28–35. doi: 10.1056/NEJM199207023270106. [DOI] [PubMed] [Google Scholar]
  46. Marcon M. J., Powell D. A. Human infections due to Malassezia spp. Clin Microbiol Rev. 1992 Apr;5(2):101–119. doi: 10.1128/cmr.5.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. McCray E., Rampell N., Solomon S. L., Bond W. W., Martone W. J., O'Day D. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol. 1986 Oct;24(4):625–628. doi: 10.1128/jcm.24.4.625-628.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Meunier-Carpentier F., Kiehn T. E., Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med. 1981 Sep;71(3):363–370. doi: 10.1016/0002-9343(81)90162-5. [DOI] [PubMed] [Google Scholar]
  49. Nelson S. C., Yau Y. C., Richardson S. E., Matlow A. G. Improved detection of Malassezia species in lipid-supplemented Peds Plus blood culture bottles. J Clin Microbiol. 1995 Apr;33(4):1005–1007. doi: 10.1128/jcm.33.4.1005-1007.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Otaki M., Kitamura N. Candida prosthetic valve endocarditis. An autopsy review. Int Surg. 1993 Jul-Sep;78(3):252–253. [PubMed] [Google Scholar]
  51. Pannuti C. S., Gingrich R. D., Pfaller M. A., Wenzel R. P. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol. 1991 Jan;9(1):77–84. doi: 10.1200/JCO.1991.9.1.77. [DOI] [PubMed] [Google Scholar]
  52. Paparello S. F., Parry R. L., MacGillivray D. C., Brock N., Mayers D. L. Hospital-acquired wound mucormycosis. Clin Infect Dis. 1992 Jan;14(1):350–352. doi: 10.1093/clinids/14.1.350. [DOI] [PubMed] [Google Scholar]
  53. Patterson T. F., Andriole V. T., Zervos M. J., Therasse D., Kauffman C. A. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses. 1990 Jun;33(6):297–302. [PubMed] [Google Scholar]
  54. Paul J., White S. H., Nicholls K. M., Crook D. W. Prosthetic joint infection due to Candida parapsilosis in the UK: case report and literature review. Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):847–849. doi: 10.1007/BF01960889. [DOI] [PubMed] [Google Scholar]
  55. Perfect J. R., Ketabchi N., Cox G. M., Ingram C. W., Beiser C. L. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol. 1993 Dec;31(12):3305–3309. doi: 10.1128/jcm.31.12.3305-3309.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Pettit T. H., Olson R. J., Foos R. Y., Martin W. J. Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol. 1980 Jun;98(6):1025–1039. doi: 10.1001/archopht.1980.01020031015002. [DOI] [PubMed] [Google Scholar]
  57. Pfaller M. A. Epidemiological typing methods for mycoses. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S4–10. doi: 10.1093/clinids/14.supplement_1.s4. [DOI] [PubMed] [Google Scholar]
  58. Pfaller M. A. Epidemiology and control of fungal infections. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S8–13. doi: 10.1093/clinids/19.supplement_1.s8. [DOI] [PubMed] [Google Scholar]
  59. Pfaller M. A. The use of molecular techniques for epidemiologic typing of Candida species. Curr Top Med Mycol. 1992;4:43–63. doi: 10.1007/978-1-4612-2762-5_2. [DOI] [PubMed] [Google Scholar]
  60. Pfaller M., Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):287–291. doi: 10.1007/BF01962067. [DOI] [PubMed] [Google Scholar]
  61. Reagan D. R., Pfaller M. A., Hollis R. J., Wenzel R. P. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol. 1990 Dec;28(12):2733–2738. doi: 10.1128/jcm.28.12.2733-2738.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Reingold A. L., Lu X. D., Plikaytis B. D., Ajello L. Systemic mycoses in the United States, 1980-1982. J Med Vet Mycol. 1986 Dec;24(6):433–436. [PubMed] [Google Scholar]
  63. Rex J. H., Pfaller M. A., Rinaldi M. G., Polak A., Galgiani J. N. Antifungal susceptibility testing. Clin Microbiol Rev. 1993 Oct;6(4):367–381. doi: 10.1128/cmr.6.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Rhame F. S. Prevention of nosocomial aspergillosis. J Hosp Infect. 1991 Jun;18 (Suppl A):466–472. doi: 10.1016/0195-6701(91)90058-g. [DOI] [PubMed] [Google Scholar]
  65. Richet H. M., Andremont A., Tancrede C., Pico J. L., Jarvis W. R. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis. 1991 Mar-Apr;13(2):211–215. doi: 10.1093/clinids/13.2.211. [DOI] [PubMed] [Google Scholar]
  66. Richet H. M., McNeil M. M., Davis B. J., Duncan E., Strickler J., Nunley D., Jarvis W. R., Tablan O. C. Aspergillus fumigatus sternal wound infections in patients undergoing open heart surgery. Am J Epidemiol. 1992 Jan 1;135(1):48–58. doi: 10.1093/oxfordjournals.aje.a116201. [DOI] [PubMed] [Google Scholar]
  67. Richet H. M., McNeil M. M., Edwards M. C., Jarvis W. R. Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit. J Clin Microbiol. 1989 Jun;27(6):1197–1200. doi: 10.1128/jcm.27.6.1197-1200.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Romano F., Ribera G., Giuliano M. A study of a hospital cluster of systemic candidosis using DNA typing methods. Epidemiol Infect. 1994 Apr;112(2):393–398. doi: 10.1017/s0950268800057800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Rowsey J. J., Acers T. E., Smith D. L., Mohr J. A., Newsom D. L., Rodriguez J. Fusarium oxysporum endophthalmitis. Arch Ophthalmol. 1979 Jan;97(1):103–105. doi: 10.1001/archopht.1979.01020010043010. [DOI] [PubMed] [Google Scholar]
  70. Sanchez V., Vazquez J. A., Barth-Jones D., Dembry L., Sobel J. D., Zervos M. J. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol. 1992 Nov;30(11):3005–3008. doi: 10.1128/jcm.30.11.3005-3008.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Sanchez V., Vazquez J. A., Barth-Jones D., Dembry L., Sobel J. D., Zervos M. J. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med. 1993 Jun;94(6):577–582. doi: 10.1016/0002-9343(93)90207-6. [DOI] [PubMed] [Google Scholar]
  72. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  73. Schwartz R. S., Mackintosh F. R., Schrier S. L., Greenberg P. L. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer. 1984 Feb 1;53(3):411–419. doi: 10.1002/1097-0142(19840201)53:3<411::aid-cncr2820530308>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  74. Schönian G., Meusel O., Tietz H. J., Meyer W., Gräser Y., Tausch I., Presber W., Mitchell T. G. Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses. 1993 May-Jun;36(5-6):171–179. doi: 10.1111/j.1439-0507.1993.tb00746.x. [DOI] [PubMed] [Google Scholar]
  75. Senba M., Watanabe K., Yoshida K., Ochi S., Matsumoto K., Yano K., Itakura H. Endocarditis caused by Candida parapsilosis. Southeast Asian J Trop Med Public Health. 1992 Mar;23(1):138–141. [PubMed] [Google Scholar]
  76. Solomon S. L., Alexander H., Eley J. W., Anderson R. L., Goodpasture H. C., Smart S., Furman R. M., Martone W. J. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis. 1986 Nov-Dec;5(6):680–685. doi: 10.1097/00006454-198611000-00016. [DOI] [PubMed] [Google Scholar]
  77. Solomon S. L., Khabbaz R. F., Parker R. H., Anderson R. L., Geraghty M. A., Furman R. M., Martone W. J. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis. 1984 Jan;149(1):98–102. doi: 10.1093/infdis/149.1.98. [DOI] [PubMed] [Google Scholar]
  78. States B., Segal S. Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normals. Life Sci. 1980 Nov 24;27(21):1985–1990. doi: 10.1016/0024-3205(80)90419-1. [DOI] [PubMed] [Google Scholar]
  79. Stuart S. M., Lane A. T. Candida and Malassezia as nursery pathogens. Semin Dermatol. 1992 Mar;11(1):19–23. [PubMed] [Google Scholar]
  80. Summerbell R. C. The benomyl test as a fundamental diagnostic method for medical mycology. J Clin Microbiol. 1993 Mar;31(3):572–577. doi: 10.1128/jcm.31.3.572-577.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Symoens F., Viviani M. A., Nolard N. Typing by immunoblot of Aspergillus fumigatus from nosocomial infections. Mycoses. 1993 Jul-Aug;36(7-8):229–237. [PubMed] [Google Scholar]
  82. Vazquez J. A., Sanchez V., Dmuchowski C., Dembry L. M., Sobel J. D., Zervos M. J. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis. 1993 Jul;168(1):195–201. doi: 10.1093/infdis/168.1.195. [DOI] [PubMed] [Google Scholar]
  83. Walmsley S., Devi S., King S., Schneider R., Richardson S., Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J. 1993 Aug;12(8):673–682. doi: 10.1097/00006454-199308000-00009. [DOI] [PubMed] [Google Scholar]
  84. Walsh T. J., Dixon D. M. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol. 1989 Jun;5(2):131–142. doi: 10.1007/BF00156818. [DOI] [PubMed] [Google Scholar]
  85. Walsh T. J., Melcher G. P., Rinaldi M. G., Lecciones J., McGough D. A., Kelly P., Lee J., Callender D., Rubin M., Pizzo P. A. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol. 1990 Jul;28(7):1616–1622. doi: 10.1128/jcm.28.7.1616-1622.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Walsh T. J., Newman K. R., Moody M., Wharton R. C., Wade J. C. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) 1986 Jul;65(4):268–279. doi: 10.1097/00005792-198607000-00005. [DOI] [PubMed] [Google Scholar]
  87. Weems J. J., Jr, Andremont A., Davis B. J., Tancrede C. H., Guiguet M., Padhye A. A., Squinazi F., Martone W. J. Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients. J Clin Microbiol. 1987 Aug;25(8):1459–1462. doi: 10.1128/jcm.25.8.1459-1462.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Weems J. J., Jr Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis. 1992 Mar;14(3):756–766. doi: 10.1093/clinids/14.3.756. [DOI] [PubMed] [Google Scholar]
  89. Weems J. J., Jr, Chamberland M. E., Ward J., Willy M., Padhye A. A., Solomon S. L. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol. 1987 Jun;25(6):1029–1032. doi: 10.1128/jcm.25.6.1029-1032.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Welbel S. F., McNeil M. M., Pramanik A., Silberman R., Oberle A. D., Midgley G., Crow S., Jarvis W. R. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit. Pediatr Infect Dis J. 1994 Feb;13(2):104–108. doi: 10.1097/00006454-199402000-00005. [DOI] [PubMed] [Google Scholar]
  91. Wenzel R. P., Pfaller M. A. Candida species: emerging hospital bloodstream pathogens. Infect Control Hosp Epidemiol. 1991 Sep;12(9):523–524. doi: 10.1086/646403. [DOI] [PubMed] [Google Scholar]
  92. Wey S. B., Mori M., Pfaller M. A., Woolson R. F., Wenzel R. P. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988 Dec;148(12):2642–2645. doi: 10.1001/archinte.148.12.2642. [DOI] [PubMed] [Google Scholar]
  93. Wey S. B., Mori M., Pfaller M. A., Woolson R. F., Wenzel R. P. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989 Oct;149(10):2349–2353. [PubMed] [Google Scholar]
  94. Wiley J. M., Smith N., Leventhal B. G., Graham M. L., Strauss L. C., Hurwitz C. A., Modlin J., Mellits D., Baumgardner R., Corden B. J. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J Clin Oncol. 1990 Feb;8(2):280–286. doi: 10.1200/JCO.1990.8.2.280. [DOI] [PubMed] [Google Scholar]
  95. Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991 Oct 31;325(18):1274–1277. doi: 10.1056/NEJM199110313251803. [DOI] [PubMed] [Google Scholar]
  96. Winston D. J., Chandrasekar P. H., Lazarus H. M., Goodman J. L., Silber J. L., Horowitz H., Shadduck R. K., Rosenfeld C. S., Ho W. G., Islam M. Z. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med. 1993 Apr 1;118(7):495–503. doi: 10.7326/0003-4819-118-7-199304010-00003. [DOI] [PubMed] [Google Scholar]
  97. Young J. B., Ahmed-Jushuf I. H., Brownjohn A. M., Parsons F. M., Foulkes S. J., Evans E. G. Opportunistic peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol. 1984 Nov;22(5):268–269. [PubMed] [Google Scholar]
  98. Young R. C., Bennett J. E., Vogel C. L., Carbone P. P., DeVita V. T. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970 Mar;49(2):147–173. doi: 10.1097/00005792-197003000-00002. [DOI] [PubMed] [Google Scholar]
  99. Yu V. L., Muder R. R., Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med. 1986 Aug;81(2):249–254. doi: 10.1016/0002-9343(86)90259-7. [DOI] [PubMed] [Google Scholar]
  100. el-Mohandes A. E., Johnson-Robbins L., Keiser J. F., Simmens S. J., Aure M. V. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J. 1994 Jun;13(6):520–524. doi: 10.1097/00006454-199406000-00011. [DOI] [PubMed] [Google Scholar]
  101. van Belkum A., Boekhout T., Bosboom R. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J Clin Microbiol. 1994 Oct;32(10):2528–2532. doi: 10.1128/jcm.32.10.2528-2532.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES